Jennifer Bradford
Pediatrics · Manassas, VANPI 1073868261
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.6% of the total across 86 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by Supernus Pharmaceuticals, Inc. at 25.8% of the total. Reporting peaked in 2024 at $519 and has fallen 57.0% since, to $223 in 2025. Among pediatrics clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 86 payments — averaging $19.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$423
- Ironshore Pharmaceuticals Inc.$173
- Cranial Technologies, Inc$140
- Takeda Pharmaceuticals U.S.A., Inc.$113
- GSK$89
- AbbVie$78
- plus $622 from 18 others
What the payments were for
- Food & beverage$1,58397%
- Education$563%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 16 | $423 |
| Ironshore Pharmaceuticals Inc. | 9 | $173 |
| Cranial Technologies, Inc | 9 | $140 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $113 |
| GSK | 6 | $89 |
| AbbVie | 5 | $78 |
| Merck | 4 | $73 |
| Pfizer | 5 | $68 |
| Sanofi Pasteur Inc. | 3 | $54 |
| Seqirus USA Inc | 3 | $51 |
| Ultragenyx Pharmaceutical Inc. | 3 | $49 |
| Neurelis, Inc. | 2 | $42 |
| Phadia US Inc. | 2 | $37 |
| Tris Pharma Inc | 2 | $35 |
| Neos Therapeutics, LP | 2 | $35 |
| Sobi, Inc | 2 | $28 |
| Sanofi-aventis U.S. LLC | 1 | $26 |
| Acadia Pharmaceuticals Inc | 1 | $22 |
| AstraZeneca | 1 | $21 |
| Portola Pharmaceuticals, LLC | 1 | $19 |
| Corium, LLC | 1 | $17 |
| Verrica Pharmaceuticals Inc. | 1 | $17 |
| Alk-abello, Inc | 1 | $15 |
| Noven Therapeutics, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$164
How this compares
$1,639 in reported general payments places this provider in the 90th percentile of 1,542 pediatrics providers in Virginia.
Other pediatrics in Manassas
- Patricia MulreanyMidlothian$1.5M
- Dominick PastoreRichmond$1.1M
- Judith GrossbergMidlothian$291K
- Elizabeth CullenMidlothian$289K
- Martha SaundersMidlothian$288K
- Anne Marie IraniRichmond$265K
- Ozlem Goker-AlpanFairfax$210K
- Tamara SutherlandGlen Allen$145K
- Tamara Charity-BrownPetersburg$145K
- Alan RogolCharlottesville$142K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.